XenoPort, Inc. (NASDAQ:XNPT)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Recs

0
Player Avatar franktejon (< 20) Submitted: 7/7/2010 10:25:48 PM : Outperform Start Price: $6.56 XNPT Score: -33.82

strong buy

Featured Broker Partners


Advertisement